"HIT"

USPTO USPTO 1994 CANCELLED - SECTION 8

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die US-Marke "HIT" wurde als Wortmarke am 01.11.1994 beim Amerikanischen Patent- und Markenamt angemeldet.
Sie wurde am 28.10.1997 im Markenregister eingetragen. Der aktuelle Status der Marke ist "CANCELLED - SECTION 8".

Markendetails Letztes Update: 30. April 2018

Markenform Wortmarke
Aktenzeichen 74593428
Registernummer 2108093
Anmeldedatum 01. November 1994
Veröffentlichungsdatum 05. August 1997
Eintragungsdatum 28. Oktober 1997

Markeninhaber

8 King Street East, Suite 1300
M5C 1B5 Toronto, Ontario
CA

Markenvertreter

Waren und Dienstleistungen

5 pharmaceutical preparations comprising hyaluronan, adapted for the topical, injectable, and intravenous treatment of the following - cancer, increasing activity of macrophages; reduction of swelling in the brain of person suffering brain trauma; herpes, canker sore, shingles; renal failure, cardiac insufficiency, hypertension, edema; infection, acne, monoucleosis; transplants; inflammation, elimination of tumor breakdown material (toxins and debris), decreasing side effects, relief of pain; detoxification; bronchodilation; vascular ischemia; HIV (AIDS); diabetes; post-menopause; prevention of topical infection; reduction of swelling; hypertension, cardiac insufficiency; prostaglandin synthesis inhibition; enhancement of oxygenation of tissue by perfusion fluid bathing of the tissue (for transplantation purposes); sub-retinal neovascularization and as an adjunct to the treatment of cancer to prevent metastasis; arthitis or pannus; cancer tumours; inhibiting angiogenesis; controlling angiogenesis; regressing angiogenesis; basal cell carcinoma; actinic keratoses; liver spots; squamous cell tumours; metastatic cancer of the breast to the skin; primary and metastatic melanoma of the skin; malignancies and/or tumour of the skin; genital warts (condyloma acuminata); cervical cancer; Human Papilloma Virus (HPV); psoriasis, corns on the feet; and hair loss on the heads of pregnant women; topical treatment of pain in the skin and or exposed tissue; clearing of atherosclerosis; prevention of arterial restenosis after balloon angioplasty; macrophage infilitration
42 licensing the intellectual property technology regarding pharmaceutical preparations comprising hyaluronan, adapted for the topical, injectable, and intravenous treatment of medical conditions and disease in humans
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

ID: 1374593428